Efficacy of assessing circulating cell-free DNA using a simple fluorescence assay in patients with triple-negative breast cancer receiving neoadjuvant chemotherapy: a prospective observational study

This study aims to assess cell-free DNA (CFD) by a fluorescence assay as a biomarker for early prediction of a pathologic complete response (pCR) and relapse in patients with triple-negative breast cancer (TNBC) undergoing neoadjuvant chemotherapy. Patients with clinical stage II or III TNBC schedul...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Kwonoh, Woo, Miyoung, Kim, Jeong Eun, Ahn, Jin-Hee, Jung, Kyung Hae, Roh, Jin, Gong, Gyungyub, Kim, Sung-Bae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5790507/
https://www.ncbi.nlm.nih.gov/pubmed/29423090
http://dx.doi.org/10.18632/oncotarget.23520

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5790507/
https://www.ncbi.nlm.nih.gov/pubmed/29423090
http://dx.doi.org/10.18632/oncotarget.23520

Ejemplares similares